Article
Bleomycin induces senescence and repression of DNA repair via downregulation of Rad51
22 Apr 2024
Abstract excerpt
BACKGROUND: Bleomycin, a potent antitumor agent, is limited in clinical use due to the potential for fatal pulmonary toxicity. The accelerated DNA damage and senescence in alveolar epithelial cells (AECs) is considered a key factor in the development of lung pathology. Understanding the mechanisms for bleomycin-induced lung injury is crucial for mitigating its adverse effects. METHODS: Human lung epithelial...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
